Figure of 8 Walk Test in Multiple Sclerosis
The Reliability and Validity of the Figure of 8 Walk Test in Multiple Sclerosis
1 other identifier
observational
50
1 country
1
Brief Summary
Balance disorder is common in people with MS. As the disease worsens, it is associated with impaired balance, difficulty walking, decreased mobility, and an increased risk of falling. Given the prevalence and clinical significance of balance dysfunction in individuals with MS, the assessment of balance has become an important focus in MS clinical practice and research. The figure of 8 Walk Test is a standard clinical measure used to evaluate the forward walking performance required in daily life. Beyond walking straight, turning ability is required in many situations in daily life such as walking around a table, avoiding obstacles and navigating the street. The gait characteristics of walking on a straight and curved road are different. During curved walking, the center of mass of the body shifts to the inner leg as the stance time of the inner leg increases, as opposed to walking on a straight track. Compared to other standardized tests, scoring is not dependent on the subjectivity of the examiner, can be administered by a person with minimal training, and requires minimal time, space, and equipment. The test assesses the ability to quickly change direction of movement and is a timed test involving the use of assistive devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2022
CompletedFirst Posted
Study publicly available on registry
June 27, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 6, 2022
CompletedOctober 10, 2022
October 1, 2022
2 months
June 21, 2022
October 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The Figure of Walk Test
Two cones are placed 1.5 meters apart. The individual stands in the middle of this distance. At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone. Elapsed time is recorded
First day
The Figure of Walk Test
Two cones are placed 1.5 meters apart. The individual stands in the middle of this distance. At the start of the test, he goes around the first cone as fast as he can walk around the first cone, then when he comes to the other starting point, this time around the other cone. Elapsed time is recorded
second day
Secondary Outcomes (4)
Berg Balance scale
First day
Timed up and go test
First day
Timed 25-Foot Walk test
First day
Four Square Step Test
First day
Study Arms (1)
Multiple sclerosis patient
First day, first evaluator will perform all tests, and second day, second evaluator will perform the figure of 8 walk test.
Interventions
The figure of walk test, Berg Balance scale, Timed 25-Foot Walk, Timed up and go test, Foursquare walk test
Eligibility Criteria
Multiple Sclerosis Patients
You may qualify if:
- Having an EDSS score of 4 and below,
- Being between the ages of 18-65
- Willingness to participate in the study
You may not qualify if:
- Being pregnant or within the first 3 months after giving birth,
- Receiving corticosteroid therapy in the last 1 month,
- Using drugs that will affect walking in the last 1 month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaraş Sutcu Imam University
Kahramanmaraş, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zekiye İpek Katırcı Kırmacı
Kahramanmaras Sutcu Imam University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst. Prof.
Study Record Dates
First Submitted
June 21, 2022
First Posted
June 27, 2022
Study Start
August 1, 2022
Primary Completion
October 1, 2022
Study Completion
October 6, 2022
Last Updated
October 10, 2022
Record last verified: 2022-10